The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Panitumumab Market Research Report 2025
Synopsis
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
The global Panitumumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Panitumumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Panitumumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Panitumumab in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Panitumumab include Amgen. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Panitumumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Panitumumab.
Report Scope
The Panitumumab market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Panitumumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Panitumumab companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Segment by Type
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Panitumumab companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
The global Panitumumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Panitumumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Panitumumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Panitumumab in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Panitumumab include Amgen. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Panitumumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Panitumumab.
Report Scope
The Panitumumab market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Panitumumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Panitumumab companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Segment by Type
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Panitumumab companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Panitumumab Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 100 mg/5 mL single-dose vials
1.2.3 400 mg/20 mLsingle-dose vials
1.3 Market by Application
1.3.1 Global Panitumumab Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Panitumumab Market Perspective (2019-2030)
2.2 Panitumumab Growth Trends by Region
2.2.1 Global Panitumumab Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Panitumumab Historic Market Size by Region (2019-2024)
2.2.3 Panitumumab Forecasted Market Size by Region (2025-2030)
2.3 Panitumumab Market Dynamics
2.3.1 Panitumumab Industry Trends
2.3.2 Panitumumab Market Drivers
2.3.3 Panitumumab Market Challenges
2.3.4 Panitumumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Panitumumab Players by Revenue
3.1.1 Global Top Panitumumab Players by Revenue (2019-2024)
3.1.2 Global Panitumumab Revenue Market Share by Players (2019-2024)
3.2 Global Panitumumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Panitumumab Revenue
3.4 Global Panitumumab Market Concentration Ratio
3.4.1 Global Panitumumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Panitumumab Revenue in 2023
3.5 Panitumumab Key Players Head office and Area Served
3.6 Key Players Panitumumab Product Solution and Service
3.7 Date of Enter into Panitumumab Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Panitumumab Breakdown Data by Type
4.1 Global Panitumumab Historic Market Size by Type (2019-2024)
4.2 Global Panitumumab Forecasted Market Size by Type (2025-2030)
5 Panitumumab Breakdown Data by Application
5.1 Global Panitumumab Historic Market Size by Application (2019-2024)
5.2 Global Panitumumab Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Panitumumab Market Size (2019-2030)
6.2 North America Panitumumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Panitumumab Market Size by Country (2019-2024)
6.4 North America Panitumumab Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Panitumumab Market Size (2019-2030)
7.2 Europe Panitumumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Panitumumab Market Size by Country (2019-2024)
7.4 Europe Panitumumab Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Panitumumab Market Size (2019-2030)
8.2 Asia-Pacific Panitumumab Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Panitumumab Market Size by Region (2019-2024)
8.4 Asia-Pacific Panitumumab Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Panitumumab Market Size (2019-2030)
9.2 Latin America Panitumumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Panitumumab Market Size by Country (2019-2024)
9.4 Latin America Panitumumab Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Panitumumab Market Size (2019-2030)
10.2 Middle East & Africa Panitumumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Panitumumab Market Size by Country (2019-2024)
10.4 Middle East & Africa Panitumumab Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Panitumumab Introduction
11.1.4 Amgen Revenue in Panitumumab Business (2019-2024)
11.1.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Panitumumab Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 100 mg/5 mL single-dose vials
Table 3. Key Players of 400 mg/20 mLsingle-dose vials
Table 4. Global Panitumumab Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Panitumumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Panitumumab Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Panitumumab Market Share by Region (2019-2024)
Table 8. Global Panitumumab Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Panitumumab Market Share by Region (2025-2030)
Table 10. Panitumumab Market Trends
Table 11. Panitumumab Market Drivers
Table 12. Panitumumab Market Challenges
Table 13. Panitumumab Market Restraints
Table 14. Global Panitumumab Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Panitumumab Market Share by Players (2019-2024)
Table 16. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Panitumumab as of 2023)
Table 17. Ranking of Global Top Panitumumab Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Panitumumab Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Panitumumab Product Solution and Service
Table 21. Date of Enter into Panitumumab Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Panitumumab Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Panitumumab Revenue Market Share by Type (2019-2024)
Table 25. Global Panitumumab Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Panitumumab Revenue Market Share by Type (2025-2030)
Table 27. Global Panitumumab Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Panitumumab Revenue Market Share by Application (2019-2024)
Table 29. Global Panitumumab Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Panitumumab Revenue Market Share by Application (2025-2030)
Table 31. North America Panitumumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Panitumumab Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Panitumumab Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Panitumumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Panitumumab Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Panitumumab Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Panitumumab Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Panitumumab Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Panitumumab Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Panitumumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Panitumumab Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Panitumumab Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Panitumumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Panitumumab Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Panitumumab Market Size by Country (2025-2030) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Panitumumab Product
Table 49. Amgen Revenue in Panitumumab Business (2019-2024) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Panitumumab Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Panitumumab Market Share by Type: 2023 VS 2030
Figure 3. 100 mg/5 mL single-dose vials Features
Figure 4. 400 mg/20 mLsingle-dose vials Features
Figure 5. Global Panitumumab Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Panitumumab Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Panitumumab Report Years Considered
Figure 10. Global Panitumumab Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Panitumumab Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Panitumumab Market Share by Region: 2023 VS 2030
Figure 13. Global Panitumumab Market Share by Players in 2023
Figure 14. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Panitumumab as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Panitumumab Revenue in 2023
Figure 16. North America Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Panitumumab Market Share by Country (2019-2030)
Figure 18. United States Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Panitumumab Market Share by Country (2019-2030)
Figure 22. Germany Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Panitumumab Market Share by Region (2019-2030)
Figure 30. China Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Panitumumab Market Share by Country (2019-2030)
Figure 38. Mexico Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Panitumumab Market Share by Country (2019-2030)
Figure 42. Turkey Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Panitumumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Amgen Revenue Growth Rate in Panitumumab Business (2019-2024)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
